KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2025)

ClearPoint Neuro's Non-Current Deffered Revenue history spans 8 years, with the latest figure at $769000.0 for Q3 2025.

  • For Q3 2025, Non-Current Deffered Revenue rose 60.21% year-over-year to $769000.0; the TTM value through Sep 2025 reached $769000.0, up 60.21%, while the annual FY2024 figure was $436000.0, 19.41% down from the prior year.
  • Non-Current Deffered Revenue for Q3 2025 was $769000.0 at ClearPoint Neuro, up from $603000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $769000.0 in Q3 2025 and bottomed at $253000.0 in Q2 2023.
  • The 5-year median for Non-Current Deffered Revenue is $401000.0 (2022), against an average of $415631.6.
  • The largest annual shift saw Non-Current Deffered Revenue skyrocketed 184.88% in 2021 before it tumbled 36.91% in 2023.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $264000.0 in 2021, then surged by 47.73% to $390000.0 in 2022, then soared by 38.72% to $541000.0 in 2023, then decreased by 19.41% to $436000.0 in 2024, then surged by 76.38% to $769000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Non-Current Deffered Revenue are $769000.0 (Q3 2025), $603000.0 (Q2 2025), and $357000.0 (Q1 2025).